Code | 7382E | ||||||||||
MA number | EU/1/24/1829/001 | ||||||||||
Product Form: | sol inj 1x0,6 ml/0,6 mg (pero napl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Zealand Pharma A/S, Denmark | ||||||||||
Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 24.07.2024 |
Validity: | 24.07.2029 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 05.09.2024 |